LongCovid
Currently, there are no curative therapies for Post-COVID or ME/CFS. A German study led by Charité – Universitätsmedizin Berlin proposes the evaluation of drugs targeting different mechanisms in clinical trial networks using harmonized diagnostic…
On the occasion of its first year of implementation, the Long COVID project just launched a new Press Release. Do not miss it! All Long COVID Press Releases…
Very interesting article published by Nature Communication on the natural history of the Long COVID in Scotland Study (Long-CISS), a Scotland-wide, general population cohort of adults. The study…
Very interesting interview with University of California San Francisco infectious disease specialist Michael Peluso, who co-leads one of the world’s oldest studies of the debilitating condition. What’s New…
Annals of Clinical and Translational Neurology recently published this article where the authors identified that the kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC. This opens…
A new perspective article published by Frontiers in Medicine proposes a multipronged clinical trial platform approach that addresses the complexity and heterogeneity of Post-COVID and ME/CFS, enabling to test numerous drugs in…
A new report on vaccination prevention of Long COVID across multiple cohorts & countries (the UK, Spain and Estonia) found very consistent protection (16-45% reduction), particularly in young people. This preprint article…
A new study called COVID-OUT, carried out by researchers from the University of Minnesota, found that metformin, a safe, inexpensive and widely available drug commonly used to treat…
According to a new study from the Allen Institute for Immunology and Fred Hutch, an overactive inflammatory response could be at the root of many Long COVID cases.…
New article in the Journal of Translational Medicine. The findings of this publication demonstrated that pacing is effective in the management of patients with long COVID syndrome, and…